Clinical Trials Sponsored by LMC Diabetes & Endocrinology Ltd.

Total 24 results

LMC Diabetes & Endocrinology Ltd.

Completed

Prevalence and Risk Evaluation of Diabetic Complications of the Foot in A Large Canadian Population (PEDAL)

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Onychomycosis | Foot Deformities | Neuropathy, Diabetic | Foot Ulcer, Diabetic | Hyperkeratosis | Onychauxis

Canada
LMC Diabetes & Endocrinology Ltd.

Completed

The Current Health Status of Patients Living With Type 1 Diabetes From the LMC Diabetes Patient Registry

Type1diabetes

Canada
LMC Diabetes & Endocrinology Ltd.

Completed

The Skills, Confidence & Preparedness Index (SCPI) (SCPI)

Diabetes Mellitus

Canada
LMC Diabetes & Endocrinology Ltd.

Unknown

Flexible Insulin Therapy Untethered Insulin Regimen in Avidly Exercising Patients With Type 1 Diabetes: FIT Untethered (FIT Untethered)

Type 1 Diabetes Mellitus

Canada
LMC Diabetes & Endocrinology Ltd.

Recruiting

Clinical Outcomes From Enhanced SCREENing Strategies for NASH in Type 2 Diabetes (SCREEN NASH T2D)

Type 2 Diabetes | Nonalcoholic Steatohepatitis

Canada
LMC Diabetes & Endocrinology Ltd.

Completed

The Effect of Soliqua on Glucose Variability in Type 2 Patients Among South Asians (VARIATION 2 SA)

Diabetes Mellitus, Type 2

Canada
LMC Diabetes & Endocrinology Ltd.

Completed

Real-world Health Outcomes in Canadian Patients Using Semaglutide

Type 2 Diabetes

Canada
LMC Diabetes & Endocrinology Ltd.

Completed

Measurement of Alanine Aminotransaminase (ALT) Following Initiation of Antidiabetic Agents in Patients With Type 2 Diabetes in a Real-world Clinical Setting: a Retrospective Cohort Study (ALT)

Fatty Liver | NAFLD | T2DM (Type 2 Diabetes Mellitus)

Canada
LMC Diabetes & Endocrinology Ltd.
Sanofi

Completed

Long Acting Insulin Glargine Titration Web Tool (LTHome) vs Enhanced Usual Therapy of Glargine Titration (INNOVATE)

Type 2 Diabetes Mellitus

Canada
LMC Diabetes & Endocrinology Ltd.
Sanofi

Unknown

Optimal Insulin Correction Factor in Post- High Intensity Exercise Hyperglycemia in Adults With Type 1 Diabetes (FIT) (FIT)

Diabetes Mellitus, Type 1

Canada
LMC Diabetes & Endocrinology Ltd.
Abbott Diabetes Care

Completed

Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy (IMMEDIATE)

Diabetes Mellitus, Type 2 | Glucose

Canada
LMC Diabetes & Endocrinology Ltd.
Insulet Corporation

Completed

Canadian Real-World Outcomes of Omnipod Initiation in People With T1D (COPPER)

Diabetes Mellitus, Type 1

Canada
Bayer
LMC Diabetes & Endocrinology

Completed

Survey of Patient and Physician Awareness and Values to the Diagnosis and Treatment of Reduced Kidney Function (Chronic Kidney Disease) in Patients With High Blood Sugar Level (Type 2 Diabetes) (AWARE-CKD in T2D) (AWARE-CKD)

Renal Insufficiency, Chronic

Canada
LMC Diabetes & Endocrinology Ltd.
Bausch Health Americas, Inc.

Completed

Randomized Trial Comparing Colesevelam vs. Ezetimibe (GOAL-RCT)

Type 2 Diabetes Mellitus

Canada
LMC Diabetes & Endocrinology Ltd.
Novo Nordisk Canada Inc.

Completed

Impact of GLP-1 RAs Compared to Basal Insulin Start in Patients Living With Type 2 Diabetes and Chronic Kidney Disease

Chronic Kidney Diseases | Type 2 Diabetes

Canada
LMC Diabetes & Endocrinology Ltd.
Merck Sharp & Dohme LLC; Syreon Corporation

Withdrawn

Approaches To Therapy Escalation In T2D (ATTACC)

Type2 Diabetes
LMC Diabetes & Endocrinology Ltd.
Public Health Agency of Canada (PHAC)

Active, not recruiting

The Canadian Diabetes Prevention Program (CDPP)

Diabetes type2

Canada
Texas Diabetes & Endocrinology, P.A.
Amylin Pharmaceuticals, LLC.

Terminated

Safety Study of Using Symlin Alongside Insulin in a Multiple Injection Port

Type 1 Diabetes | Type 2 Diabetes

United States
Diabetes Frail Ltd
Merck Sharp & Dohme LLC; University of Campania "Luigi Vanvitelli"

Withdrawn

DiaFrail: A Short Duration Study in Older People ( DIAFRAIL Study) (DiaFrail)

Diabetes Mellitus
University of Virginia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); DexCom... and other collaborators

Completed

Project Nightlight: Efficacy and System Acceptance of Dinner/Night vs. 24hr Closed Loop Control

Diabetes Mellitus, Type 1

United States
University Hospital Tuebingen
University Hospital Heidelberg; University Hospital Carl Gustav Carus; German... and other collaborators

Completed

Individualized Lifestyle Intervention in Subjects With Prediabetes (PLIS)

Diabetes Mellitus Type 2

Germany
University of Virginia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); DexCom... and other collaborators

Completed

International Diabetes Closed Loop (iDCL) Trial: Research Site Training Protocol

Diabetes Mellitus, Type 1

United States, Netherlands, France, Italy
Alessandro Doria
University of Colorado, Denver; University Health Network, Toronto; University... and other collaborators

Not yet recruiting

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease (SUGARNSALT)

Heart Failure | Diabetic Nephropathies | Kidney Failure, Chronic | Diabetes Mellitus Type 1

Canada, United States
Michael Mauer, MD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Merck... and other collaborators

Completed

Renin Angiotensin System Study (RASS/B-RASS)

Type 1 Diabetes

Canada

Clinical Trials Sponsored by LMC Diabetes & Endocrinology Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Benin

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations